Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 4Prostatic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Melanoma 2Lung Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Small Cell Lung Carcinoma 1Sarcoma 1Prostate Adenocarcinoma 1Mesothelioma, Malignant 1Lymphatic Metastasis 1Carcinoma, Renal Cell 1Carcinoma, Merkel Cell 1Breast Carcinoma In Situ 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

luprolide acetate gel depot 2Leuprolide 2Goserelin 2radium Ra 223 dichloride 1niraparib 1apalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Watchful Waiting 1Triptorelin Pamoate 1Receptors, Bombesin 1Radiotherapy 1Radiosurgery 1Radiation Dose Hypofractionation 1Radiation 1Observation 1Neoadjuvant Therapy 1Methods 1Magnetic Resonance Spectroscopy 1Gallium 1Educational Status 1Early Intervention, Educational 1Counseling 1Cholecalciferol 1BAY 86-7548 1Adjuvants, Pharmaceutic 168Ga-bombesin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Prostate Adenocarcinoma × Radiation Dose Hypofractionation × Clear all
NCT03274687 2026-05-20

Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

NRG Oncology

Phase 3 Completed
296 enrolled 29 charts
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡